Alterity Therapeutics Ltd

(PRNAF)

By |

Profile

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434).

Contact Information

Website: www.alteritytherapeutics.com
Email: info@pranabio.com
Main Phone: +61 393494906
Address: 460 Bourke Street
Address 2: Level 3
State: VIC
City / Town: Melbourne
Country: AU
Postal Code: 3000

Issuer Information

Exchange: OTO
CEO: Geoffrey Paul Kempler
Employees: 12

Equities News

Profile

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434).

Contact Information

Website: www.alteritytherapeutics.com
Email: info@pranabio.com
Main Phone: +61 393494906
Address: 460 Bourke Street
Address 2: Level 3
State: VIC
City / Town: Melbourne
Country: AU
Postal Code: 3000

Issuer Information

Exchange: OTO
CEO: Geoffrey Paul Kempler
Employees: 12

Equities News

$ 0.0341 $ 0. (0.00%)
Last Price 0.0341 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 0.0341 High 0.0341 Low 0.0341 Prev Close 0.0341
Last Trade Volume 2,759 52 Wk Hi 0.07 52 Wk Low 0.01
Market Cap 46.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 1,356,255,039.00 EPS (TTM) N/A PE Ratio N/A Exchange OTCPK